Labcorp Holdings Inc. (LH)

NYSE: LH · Real-Time Price · USD
238.56
-0.21 (-0.09%)
Jan 17, 2025, 4:00 PM EST - Market closed
-0.09%
Market Cap 19.95B
Revenue (ttm) 12.71B
Net Income (ttm) 435.50M
Shares Out 83.64M
EPS (ttm) 5.14
PE Ratio 46.46
Forward PE 15.57
Dividend $2.88 (1.21%)
Ex-Dividend Date Nov 26, 2024
Volume 538,352
Open 239.33
Previous Close 238.77
Day's Range 236.95 - 242.74
52-Week Range 191.97 - 247.99
Beta 1.04
Analysts Buy
Price Target 260.07 (+9.02%)
Earnings Date Feb 6, 2025

About LH

Labcorp Holdings Inc. provides laboratory services. It operates through two segments, Diagnostics Laboratories and Biopharma Laboratory Services. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid, PAP, hemoglobin A1C and vitamin D, prostate-specific antigens, sexually transmitted diseases, hepatitis C, microbiology cultures and procedures, and alcohol and other substance-abuse tests. It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests tar... [Read more]

Sector Healthcare
Founded 1971
Employees 67,000
Stock Exchange NYSE
Ticker Symbol LH
Full Company Profile

Financial Performance

In 2023, Labcorp Holdings's revenue was $12.16 billion, an increase of 2.51% compared to the previous year's $11.86 billion. Earnings were $418.00 million, a decrease of -67.32%.

Financial Statements

Analyst Forecast

According to 16 analysts, the average rating for LH stock is "Buy." The 12-month stock price forecast is $260.07, which is an increase of 9.02% from the latest price.

Price Target
$260.07
(9.02% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Labcorp to Speak at the 43rd Annual J.P. Morgan Healthcare Conference

BURLINGTON, N.C. , Jan. 10, 2025 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that the company will participate in a firesid...

10 days ago - PRNewsWire

LABCORP DECLARES QUARTERLY DIVIDEND

BURLINGTON, N.C. , Jan. 8, 2025 /PRNewswire/ -- Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that its Board of Directors has d...

11 days ago - PRNewsWire

Labcorp to Announce Fourth Quarter Financial Results on February 6, 2025

BURLINGTON, N.C. , Jan. 8, 2025 /PRNewswire/ -- Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, will release its financial results for the fourth...

12 days ago - PRNewsWire

Geneoscopy Closes $105M in Series C Funding Round to Power Next-Generation of Gastrointestinal Diagnostic Tests

ST. LOUIS & HERCULES, Calif.--(BUSINESS WIRE)--Geneoscopy raises $105 million in Series C funding round, led by Bio-Rad Laboratories.

Other symbols: BIO
12 days ago - Business Wire

Labcorp Launches H5 Bird Flu Test in the U.S., Now Available for Order through Physicians

New test supports public health preparedness efforts and testing infrastructure amid multistate outbreak of H5 bird flu in poultry and dairy cows BURLINGTON, N.C. , Dec. 17, 2024 /PRNewswire/ -- Labco...

4 weeks ago - PRNewsWire

Be Patient, Earn Dividends From Labcorp, The Leading Patient Clinical Lab Brand

For my initial coverage of Labcorp, I'm calling it a hold, and an opportunity to earn a $0.72/share quarterly dividend on the leading clinical lab company in the US. The firm shows future growth indic...

7 weeks ago - Seeking Alpha

Outcomes4Me and Labcorp Study Reveals Digital Education Can Increase HER2-low Awareness for Metastatic Breast Cancer Patients

Research to be presented in a joint poster session with Labcorp at the 2024 San Antonio Breast Cancer Symposium BOSTON and BURLINGTON, N.C. , Nov. 26, 2024 /PRNewswire/ -- Outcomes4Me Inc., the develo...

7 weeks ago - PRNewsWire

Cinven secures Italian nod to sell minority stake in Synlab to Labcorp

Private equity firm Cinven secured a conditional approval from Italian authorities over its plan to sell a 15% stake in diagnostic service provider Synlab to laboratory operator Labcorp , a government...

2 months ago - Reuters

Labcorp CFO Glenn Eisenberg Announces Plans to Retire

Julia Wang Named Chief Financial Officer Beginning December 2, 2024 BURLINGTON, N.C. , Nov. 19, 2024 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory serv...

2 months ago - PRNewsWire

Praia Health Secures Strategic Investment from Labcorp Venture Fund, Announces New Collaboration to Streamline Patient Lab Ordering Experience

CHICAGO & BURLINGTON, N.C.--(BUSINESS WIRE)--Collaboration leverages Praia Health's technology and Labcorp's comprehensive testing capabilities to streamline and personalize patient experience.

2 months ago - Business Wire

Labcorp Holdings Inc. (LH) Q3 2024 Earnings Call Transcript

Labcorp Holdings Inc. (NYSE:LH) Q3 2024 Earnings Conference Call October 24, 2024 9:00 AM ET Company Participants Christin O'Donnell – Vice President-Investor Relations Adam Schechter – Chairman and ...

3 months ago - Seeking Alpha

Laboratory Corp Q3 Earnings Beat Street View, Investors Overlook Hurricane Helene Impact

Thursday, Laboratory Corp  LH reported third-quarter 2024 adjusted earnings per share of $3.50, up from $3.38 a year ago, beating the consensus of $3.49.

3 months ago - Benzinga

Labcorp beats quarterly estimates on diagnostic test demand

Laboratory operator Labcorp on Thursday beat Wall Street estimates for third-quarter profit and revenue, helped by demand for diagnostic tests.

3 months ago - Reuters

Labcorp Announces 2024 Third Quarter Results

Updates Full-Year Guidance Results from Continuing Operations for third quarter 2024 versus last year: Revenue: $3.28 billion versus $3.06 billion Diluted EPS: $2.00 versus $2.11 Adjusted EPS: $3.50 v...

3 months ago - PRNewsWire

NOWDiagnostics and Labcorp Collaborate to Expand Access to the Only FDA-Marketing Authorized Over-the-Counter Syphilis Test in the U.S.

SPRINGDALE, Ark.--(BUSINESS WIRE)--NOWDiagnostics, Inc. (NOWDx), a developer of over-the-counter (OTC) and point-of-care (POC) diagnostic tests, today announced that Labcorp, a global leader of innova...

3 months ago - Business Wire

Labcorp Expands Sexually Transmitted Infection (STI) Test Offerings with Rapid Syphilis Test

Labcorp to serve as the exclusive NOWDiagnostics (NOWDx) distributor for clinical testing in the U.S., offering First to Know® Syphilis Test nationwide BURLINGTON, N.C. , Oct 10, 2024 /PRNewswire/ -- ...

3 months ago - PRNewsWire

Labcorp Declares Quarterly Dividend

BURLINGTON, N.C. , Oct. 10, 2024 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that its Board of Directors has declared a cas...

3 months ago - PRNewsWire

Labcorp to Announce Third Quarter Financial Results on October 24, 2024

BURLINGTON, N.C. , Sept. 24, 2024 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, will release its financial results for the third quarter of 2...

4 months ago - PRNewsWire

CommonWell Health Alliance Welcomes Labcorp as Newest Member

BOSTON--(BUSINESS WIRE)--CommonWell Health Alliance is excited to welcome Labcorp, a global leader of innovative and comprehensive laboratory services, as one of its newest members in the ongoing jour...

4 months ago - Business Wire

Ovia Health Expands Women's Health Offerings with Comprehensive Postpartum Experience

New solution is the first holistic program available in a digital app to help women manage the postpartum period BOSTON , Sept. 18, 2024 /PRNewswire/ -- Ovia Health by Labcorp (Ovia) today announced t...

4 months ago - PRNewsWire

LABCORP PRICES $650,000,000 IN 4.350% SENIOR NOTES DUE 2030, $500,000,000 IN 4.550% SENIOR NOTES DUE 2032 AND $850,000,000 IN 4.800% SENIOR NOTES DUE 2034

BURLINGTON, N.C. , Sept. 16, 2024 /PRNewswire/ -- Labcorp Holdings Inc. (NYSE:LH) (Labcorp) announced today that its wholly owned subsidiary, Laboratory Corporation of America Holdings (LCAH), has pri...

4 months ago - PRNewsWire

Labcorp Completes Acquisition of Select Assets of BioReference Health's Diagnostics Business from OPKO Health

Enhances Labcorp's laboratory services network and expands access to its clinical services  BURLINGTON, N.C. and MIAMI , Sept.

Other symbols: OPK
4 months ago - PRNewsWire

Xcell Biosciences Advances Labcorp Collaboration with Novel Platform for Automated Cell and Gene Therapy Manufacturing

SAN FRANCISCO--(BUSINESS WIRE)--Xcell Biosciences Inc. (Xcellbio), an instrumentation company focused on cell and gene therapy applications, today announced it has advanced its collaboration with Labc...

4 months ago - Business Wire

Labcorp to Speak at the Baird 2024 Global Healthcare Conference

BURLINGTON, N.C. , Sept. 3, 2024 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that members of the executive management team ...

4 months ago - PRNewsWire

Labcorp says it could ramp up mpox testing capacity

Diagnostics firm Labcorp said it is processing approximately 500 mpox tests a month but have the capacity to process approximately 25,000 per month.

5 months ago - Reuters